Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NetApp | NTAP | Dec 26, 2024 | 118.35 | -0.41 |
Netcapital | NCPL | Dec 26, 2024 | 1.99 | +4.19 |
Netclass Technology | NTCL | Dec 26, 2024 | 5.44 | 0.00 |
NetEase ADR | NTES | Dec 26, 2024 | 92.31 | +0.10 |
Netflix | NFLX | Dec 26, 2024 | 924.14 | -0.86 |
NETGEAR | NTGR | Dec 26, 2024 | 29.03 | +2.25 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Dec 26, 2024 | 45.27 | +0.35 |
NetScout Systems | NTCT | Dec 26, 2024 | 21.87 | -0.27 |
NETSOL Technologies | NTWK | Dec 26, 2024 | 2.62 | +0.77 |
Netstreit | NTST | Dec 26, 2024 | 14.10 | -0.07 |
Network-1 Technologies | NTIP | Dec 26, 2024 | 1.38 | +2.66 |
Neuberger Berman | NML | Dec 26, 2024 | 8.62 | -1.37 |
Neuberger Berman High Yield Strategies Fund | NHS | Dec 26, 2024 | 7.65 | +0.59 |
Neuberger Berman Municipal Fund | NBH | Dec 26, 2024 | 10.27 | +0.34 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Dec 26, 2024 | 13.02 | +0.08 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Dec 26, 2024 | 3.45 | -0.72 |
NeueHealth | NEUE | Dec 26, 2024 | 7.27 | -3.58 |
Neumora Therapeutics | NMRA | Dec 26, 2024 | 11.34 | +6.68 |
Neuraxis | NRXS | Dec 26, 2024 | 2.40 | -0.41 |
Neurobo Pharmaceuticals | NRBO | Dec 26, 2024 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | Dec 26, 2024 | 139.03 | +1.83 |
Neurogene | NGNE | Dec 26, 2024 | 24.10 | +6.54 |
NeuroMetrix | NURO | Dec 26, 2024 | 3.92 | -0.08 |
Neuronetics | STIM | Dec 26, 2024 | 1.42 | -2.74 |
NeuroOne | NMTC | Dec 26, 2024 | 0.86 | +11.85 |
Neuropace | NPCE | Dec 26, 2024 | 11.35 | +1.89 |
NeuroSense Therapeutics | NRSN | Dec 26, 2024 | 1.27 | -0.78 |
Nevro | NVRO | Dec 26, 2024 | 4.05 | +2.02 |
New America High Income Fund | HYB | Dec 26, 2024 | 8.20 | +0.37 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | Dec 26, 2024 | 2.10 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.